AIG
SGNT

American International Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

American International Group’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,840
Closed -$282K – 3064
2016
Q2 		$282K Buy
18,840
+1,836
+11% +$23.6K ﹤0.01% 1911
2016
Q1 		$207K Buy
17,004
+826
+5% +$11.6K ﹤0.01% 2768
2015
Q4 		$257K Buy
16,178
+197
+1% +$3.1K ﹤0.01% 2574
2015
Q3 		$245K Buy
15,981
+232
+1% +$5.01K ﹤0.01% 2630
2015
Q2 		$383K Sell
15,749
-762
-5% -$18.3K ﹤0.01% 2425
2015
Q1 		$384K Buy
16,511
+113
+0.7% +$2.99K ﹤0.01% 2391
2014
Q4 		$412K Sell
16,398
-489
-3% -$14.3K ﹤0.01% 2312
2014
Q3 		$525K Buy
16,887
+2,574
+18% +$69.7K ﹤0.01% 2100
2014
Q2 		$370K Buy
14,313
+1,518
+12% +$33.7K ﹤0.01% 2436
2014
Q1 		$299K Buy
12,795
+307
+2% +$6.71K ﹤0.01% 2487
2013
Q4 		$317K Buy
12,488
+1,303
+12% +$29.4K ﹤0.01% 2372
2013
Q3 		$228K Buy
11,185
+4,724
+73% +$105K ﹤0.01% 2623
2013
Q2 		$136K Buy
+6,461
New +$115K ﹤0.01% 2892

American International Group's SGNT Position: Q3 2016 in Review

American International Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 18,840 shares — an estimated $282K sold.

American International Group first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $525K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • American International Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • American International Group sold 18,840 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $282K.
  • American International Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • American International Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $525K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on American International Group's 13F filing for Q3 2016, filed 9 Nov 2016.